Results 221 to 230 of about 307,412 (379)

Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Pharmacogenomics enables personalization of drug therapy improving effectiveness and/or safety. Dihydropyrimidine dehydrogenase [DPYD] testing prior to fluoropyrimidine chemotherapy was commissioned by NHS England in response to an update from the Medicines and Healthcare products Regulatory Agency.
Nisha Shaunak   +5 more
wiley   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki   +3 more
wiley   +1 more source

The Auditory Perception of Consonant Contrasts in Cochlear Implant Children. [PDF]

open access: yesIndian J Otolaryngol Head Neck Surg, 2022
Eshaghi M, Darouie A, Teymouri R.
europepmc   +1 more source

Validity of the Medication Safety Self‐Assessment for Long‐Term Care tool in Australian long‐term care: a RAND appropriateness method study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims The validity of using the Canadian Medication Safety Self‐Assessment for Long‐Term Care (MSSA‐LTC) tool in the international context is unknown. This study aims to determine the face and content validity of the Canadian MSSA‐LTC tool for assessing medication safety‐related processes in the Australian long‐term care (LTC) setting.
Ramesh Sharma Poudel   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy